Faster global financial news!
Gene Therapy
-
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Adarx Pharmaceuticals Inc., a San Diego-based late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering on Thursday. The company priced its shares at the top
-
Ultragenyx (RARE) gene therapy Genglycos approved by FDA for treatment of Glycogen Storage Disease Type Ia, shares up 7.5% after hours.
The one-time gene therapy is the first approved therapy designed to address the underlying cause of Glycogen Storage Disease Type Ia (GSDIa), with a list price in the United States of approximately $2
-
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Adarx Pharmaceuticals Inc., a San Diego-based late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering on Thursday. The company priced its shares at the top
-
Ultragenyx (RARE) gene therapy Genglycos approved by FDA for treatment of Glycogen Storage Disease Type Ia, shares up 7.5% after hours.
The one-time gene therapy is the first approved therapy designed to address the underlying cause of Glycogen Storage Disease Type Ia (GSDIa), with a list price in the United States of approximately $2
- No data
Gene Therapy
24H Trending
-
1
Financial Times: Five Signals Warning of Approaching AI Bubble and US Debt Crisis
-
2
Wall Street's Rate Shock Spreads Beneath AI-Fueled Market Rally, Driven by High Oil Prices and Borrowing Costs
-
3
Ethereum whales were liquidated for 28,716 ETH, worth nearly $70 million.
-
4
According to Bloomberg Markets: Large asset managers are deleveraging in the U.S. Treasury futures market, triggered by forced selling as cash yields approach multi-year highs.
-
5
TypeSafe AI, the maker of the non-text AI model Jev, reached a valuation of $7.5 billion just weeks after its launch, with a16z leading an $870 million funding round.
-
6
The DXY recorded its longest winning streak since early 2025, rising nearly 3% this week.
-
7
China State Funds Double Down on Hua Hong with $2.9 Billion Injection to Boost Legacy Chip Production
-
8
LAUNCHCOIN: Solana Ecosystem's "One-Click Token Issuance" Platform Analysis and Market Status
-
9
DDX (DerivaDAO) Token Analysis: Mechanism, Utility, and Market Status
-
10
BEPR Token Analysis: Distinguishing Between Homonymous Projects and Current Market Status
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
